Belgium vs Netherlands: Proportion of isolates with resistance to azithromycin reported to
Belgium
17.6
in 2020
Netherlands
14.8
in 2020
Belgium rank
7th
Netherlands rank
10th
Proportion of isolates with resistance to azithromycin reported to over time
- Belgium
- Netherlands
How they compare
Belgium currently reports 17.6 against 14.8 in Netherlands, a difference of 2.8.
That makes Belgium's figure about 1.2 times Netherlands's.
The two have swapped places 4 times across 11 shared years of data; in 2009 it was Belgium ahead.
Belgium ranks 7th and Netherlands ranks 10th of 47 countries.
Belgium has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belgium | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.55 | 2.63 | 11.91 | Belgium |
| 2010s | 5.82 | 3.98 | 1.83 | Belgium |
| 2020s | 17.6 | 14.8 | 2.8 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with resistance to azithromycin reported to, Belgium or Netherlands?
- Belgium, at 17.6 against 14.8 in Netherlands as of 2020.
- What is the difference in proportion of isolates with resistance to azithromycin reported to between Belgium and Netherlands?
- 2.8, with Belgium ahead.
- How many years of comparable data are there for Belgium and Netherlands?
- 11 years are reported by both, from 2009 to 2020.
- How do Belgium and Netherlands rank globally for proportion of isolates with resistance to azithromycin reported to?
- Belgium ranks 7th and Netherlands ranks 10th of 47 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with resistance to azithromycin reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.